Generic developing pharmaceutical companies have been in ligation in order to invalidate a subsequent patent of Crestor

On August 17, according to the pharmaceutical industry, generic developing pharmaceutical companies which manufacture generic of Crestor that released in April, has been in ligation in order to invalidate a subsequent patent registered by the original company. This is because it is difficult to guarantee sales of not only generic drug but also complex drug which they plan to develop due to the ...